Elevance reported 2025 revenue of $199.1 billion and first-quarter 2026 revenue of $50.2 billion. The thesis depends on medical-cost control, Medicaid and Medicare trends, commercial pricing, regulation, cash flow and capital allocation.
References
Sources used in this report
SEC datasetSEC company tickers exchange datasetRetrieved 2026-05-19 · Issuer identity, ticker, exchange and CIK.SEC APISEC submissions APIRetrieved 2026-05-19 · Company identity, filing chronology and filing metadata.SEC XBRL APISEC companyfacts APIRetrieved 2026-05-19 · XBRL financial statement baseline.Annual reportElevance Health, Inc. annual report2026-02-06 · Annual business, risk and financial baseline.Quarterly reportElevance Health, Inc. latest quarterly report2026-04-22 · Latest interim financial baseline.Current reportElevance Health, Inc. Form 8-K2026-05-13 · Recent company filing chronology.Proxy statementElevance Health, Inc. proxy statement2026-03-27 · Governance and incentive context.